Process for HCV protease inhibitor intermediate

Details for Australian Patent Application No. 2008240834 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gantz, Francois; Stahr, Helmut

Agent Spruson & Ferguson

Pub. Number AU-B-2008240834

PCT Pub. Number WO2008/128921

Priority 07106771.4 24.04.07 EP

Filing date 15 April 2008

Wipo publication date 30 October 2008

Acceptance publication date 23 August 2012

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/128921 Priority application(s): WO2008/128921

23 August 2012 Application Accepted

  Published as AU-B-2008240834

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240857-Hand-operated pliers

2008240832-Histamine H3 receptor ligands comprising a cyclobutoxy group